The 2.5-kilobase pair poly(purine⅐pyrimidine) (poly(R⅐Y)) tract present in intron 21 of the polycystic kidney disease 1 (PKD1) gene has been proposed to contribute to the high mutation frequency of the gene. To evaluate this hypothesis, we investigated the growth rates of 11 Escherichia coli strains, with mutations in the nucleotide excision repair, SOS, and topoisomerase I and/or gyrase genes, harboring plasmids containing the full-length tract, six 5-truncations of the tract, and a control plasmid (pSPL3). The full-length poly(R⅐Y) tract induced dramatic losses of cell viability during the first few hours of growth and lengthened the doubling times of the populations in strains with an inducible SOS response. The extent of cell loss was correlated with the length of the poly(R⅐Y) tract and the levels of negative supercoiling as modulated by the genotype of the strains or drugs that specifically inhibited DNA gyrase or bound to DNA directly, thereby affecting conformations at specific loci. We conclude that the unusual DNA conformations formed by the PKD1 poly(R⅐Y) tract under the influence of negative supercoiling induced the SOS response pathway, and they were recognized as lesions by the nucleotide excision repair system and were cleaved, causing delays in cell division and loss of the plasmid. These data support a role for this sequence in the mutation of the PKD1 gene by stimulating repair and/or recombination functions.
Polycystic kidney disease (PKD)1 encompasses a family of closely related syndromes characterized by intraparenchymal renal cysts that are lined by a single layer of epithelial cells. The several forms of PKD include autosomal dominant polycystic kidney disease (ADPKD), which is one of the most common inherited human disorders (ϳ1 per 500 worldwide). Affected individuals typically develop large cystic kidneys, but hepatic cysts, intracranial aneurysms, and cardiac valvular abnormalities are extra-renal manifestations often associated with this disorder. Approximately half of ADPKD patients develop end stage renal disease requiring renal replacement therapy and compose ϳ5% of the chronic dialysis population in the United States (reviewed in Refs. 1-5).The genetic defect in Ͼ85% of ADPKD cases is mutations in PKD1, a gene that encodes a transcript of 14 kilobases from 46 exons spanning 50 kbp on chromosome 16p13.3 (6). The 5Ј portion of the gene (exons 1-34) is duplicated with more than 95% homology in at least three other copies on chromosome 16p13.1, from which transcripts of 20, 17, and 8.5 kilobases are released (7,8). However, it is unclear whether these PKD1-like mRNAs are translated into proteins. Polycystin-1, the product of PKD1, is thought to be involved in cell-cell and cell-matrix interactions (9 -11) and in calcium-permeable non-selective cation currents (12).Genotypic analyses of PKD1 microsatellite markers revealed that cysts originate from a single cell that, in a number of cases, underwent loss of heterozygosity. These results led to the proposal that cysts form by a "two-hit...